ASSESSING THE EFFECTIVENESS OF OPTIMIZATION STRATEGIES IN HOSPITAL CARE FOR STROKE CODE: IMPLICATIONS FOR DOOR-TO-NEEDLE TIMES

Main Article Content

Sudhair Abbas Bangash
Naeem Ullah
Dr. Abdul Wadood Kakar
Dr. Masooda Fatima
Dr. Hira Amin
Dr. Nikhilesh Jain

Keywords

Cerebrovascular Accident, Ischemic Stroke, Acute Stroke, Door-To-Needle Time, Intravenous Fibrinolysis

Abstract

Introduction: Time plays a crucial role in the success of reperfusion treatments for acute ischemic stroke. Despite clinical guidelines recommending prompt intervention, only about one-third of patients receive fibrinolysis within ≤ 60 minutes. This study aims to outline our experience in implementing a specific protocol for acute ischemic stroke treatment and assess its impact on door-to-needle times.


Methods: Starting at the conclusion of 2015, a series of measures were gradually introduced to reduce response times and optimize care for acute ischemic stroke. This included the implementation of a dedicated neurovascular team. Performance times were compared before (2013-2015) and after (2017-2019) the introduction of the protocol.


Results: A total of 182 patients were included before and 249 after the implementation of the protocol. With the introduction of all measures, the overall median door-to-needle time reduced to 45 minutes (previously 74 minutes, a 39% reduction, p < 0.001). Notably, 73.5% of patients were treated within ≤ 60 minutes, representing a 47% increase compared to the pre-protocol period (p < 0.001). The overall time to treatment (symptom-to-needle onset) decreased by an average of 20 minutes (p < 0.001).


Conclusions: The measures incorporated into our protocol led to a significant and sustained reduction in door-to-needle times, though opportunities for further improvement persist. Established mechanisms for outcome monitoring and continuous enhancement will pave the way for ongoing progress in acute ischemic stroke care

Abstract 268 | pdf Downloads 52

References

1. Alhajala, H., Hendricks‐Jones, M., Shawver, J., Amllay, A., Chen, J. T., Hajjar, M., . . . Crayne, C. (2023). Expansion of Telestroke Coverage in Community Hospitals: Unifying Stroke Care and Reducing Transfer Rate. Annals of Neurology.
2. Astasio-Picado, Á., Chueca, Y. C., López-Sánchez, M., Lozano, R. R., González-Chapado, M. T., & Ortega-Trancón, V. (2023). Analysis of the Factors Intervening in the Prehospital Time in a Stroke Code. Journal of Personalized Medicine, 13(10), 1519.
3. Aziz, Y. N., & Khatri, P. (2024). Intravenous Thrombolysis to Dissolve Acute Stroke Thrombi: Reflections on the Past Decade. Stroke, 55(1), 186-189.
4. Boss, K. (2023). Improving Metrics with a Telestroke System of Care: A Community Hospital Primary Stroke Center Experience. Kent State University.
5. Daniel, D., Maillie, L., & Dhamoon, M. S. (2024). Provider Care Segregation and Hospital‐Region Racial Disparities in the United States for Acute Ischemic Stroke and Endovascular Therapy Outcomes. Journal of the American Heart Association, e029255.
6. De Mase, A., Spina, E., Servillo, G., Barbato, S., Leone, G., Giordano, F., . . . Longo, K. (2023). Effects of immediate thrombolytic treatment in imaging area on functional outcome in patients with acute ischemic stroke. Neurological Sciences, 1-7.
7. Giorelli, M., Leone, R., Aniello, M. S., Altomare, S., Colonna, I., Liuzzi, D., . . . Di Paola, G. (2023). Bringing door-to-needle times within the European benchmarks results in better stroke patient outcomes in a spoke hospital from the Apulian Region. Neurological Sciences, 1-9.
8. Härkönen, H., Myllykangas, K., Gomes, J., Immonen, M., Kärppä, M., Hyvämäki, P., & Jansson, M. (2024). Challenges and needs in cerebrovascular disease pathway: A qualitative descriptive study from the patients' and healthcare professionals' perspectives. Journal of Advanced Nursing.
9. Harrigan, M. R., & Deveikis, J. P. (2024). Ischemic Stroke Handbook of Cerebrovascular Disease and Neurointerventional Technique (pp. 879-963): Springer.
10. Hu, Q., Hu, Y., Gu, Y., Song, X., Shen, Y., Lu, H., . . . Guo, C. (2023). Impact of the COVID‐19 pandemic on acute stroke care: An analysis of the 24‐month data from a comprehensive stroke centre in Shanghai, China. CNS Neuroscience & Therapeutics.
11. Hwong, W. Y., Ng, S. W., Tong, S. F., Ab Rahman, N., Law, W. C., Wong, S. K., . . . Sivasampu, S. (2024). Identifying factors in providing intravenous stroke thrombolysis in Malaysia: a multiple case study from the healthcare providers' perspective. BMC Health Services Research, 24(1), 1-15.
12. Inoue, H., Nishikawa, Y., Oomura, M., Hattori, T., Hayashi, Y., Yamanaka, T., . . . Madokoro, Y. (2023). A systemized strategy to reduce door‐to‐puncture time using the ELVO screen: "Code AIS". Neurology and Clinical Neuroscience.
13. Kim, D. J., Singh, N., Catanese, L., Yu, A. Y., Demchuk, A. M., Lloret-Villas, M. I., . . . Appireddy, R. (2024). Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase. Stroke.
14. Kolls, B. J., Ehrlich, M. E., Monk, L., Shah, S., Roettig, M., Iversen, E., . . . Graffagnino, C. (2024). Regionalization of stroke systems of care in the stroke belt states: The IMPROVE stroke care quality improvement program. American Heart Journal, 269, 72-83.
15. Kurniawan, M., Saputri, K. M., Mesiano, T., Yunus, R. E., Permana, A. P., Sulistio, S., . . . Harris, S. (2024). Efficacy of endovascular therapy for stroke in developing country: A single-centre retrospective observational study in Indonesia from 2017 to 2021. Heliyon, 10(1).
16. Liberman, A. L., Holl, J. L., Romo, E., Maas, M., Song, S., & Prabhakaran, S. (2023). Risk assessment of the acute stroke diagnostic process using failure modes, effects, and criticality analysis. Academic Emergency Medicine, 30(3), 187-195.
17. Man, S., Solomon, N., Mac Grory, B., Alhanti, B., Uchino, K., Saver, J. L., . . . Schwamm, L. H. (2023). Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke. Circulation.
18. Mayer-Suess, L., Rinner, H., Lang, W., Greisenegger, S., Mikšová, D., Gattringer, T., . . . Mutzenbach, J. S. (2024). Risk of stroke in patients with prior VKA or DOAC: A population-based real-world registry analysis. European Stroke Journal, 23969873231223876.
19. Meza, H. T., Inda, I. S., Ponz, M. S., Ara, J., & Moreno, J. M. (2023). Impact of a series of measures for optimization hospital code stroke care on door-to-needle times. Neurología (English Edition), 38(3), 141-149.
20. Mitsuhashi, T., Tokugawa, J., & Mitsuhashi, H. (2023). Long-term evaluation of the COVID-19 pandemic impact on acute stroke management: an analysis of the 21-month data from a medical facility in Tokyo. Acta Neurologica Belgica, 123(2), 399-406.
21. Oostema, J. A., Nickles, A., Allen, J., Ibrahim, G., Luo, Z., & Reeves, M. J. (2024). Emergency medical services compliance with prehospital stroke quality metrics is associated with faster evaluation and treatment. Stroke, 55(1), 101-109.
22. Paolucci, G., Harmon, M., Madsen, T., Jayaraman, M., Furie, K. L., Thornsbury, A., . . . Yaghi, S. (2023). Abstract WP79: Addition Of Multidisciplinary Novel Processes Reduces The Door-to-Needle Time In Acute Ischemic Stroke. Stroke, 54(Suppl_1), AWP79-AWP79.
23. Popa, D., Iancu, A., Petrica, A., Buleu, F., Williams, C. G., Sutoi, D., . . . Mederle, O. A. (2023). Emergency Department Time Targets for Interhospital Transfer of Patients with Acute Ischemic Stroke. Journal of Personalized Medicine, 14(1), 13.
24. Rawson, J., Petrone, A., & Adcock, A. (2023). Single-step Optimization in Triaging Large Vessel Occlusion Strokes: Identifying Factors to Improve Door-to-groin Time for Endovascular Therapy. Western Journal of Emergency Medicine, 24(4), 737.
25. Reziya, H., Sayifujiamali, K., Han, H.-J., Wang, X.-M., Nuerbiya, T., Nuerdong, D., . . . Wu, Y.-F. (2023). Real-time feedback on mobile application use for emergency management affects the door-to-needle time and functional outcomes in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 32(4), 107055.
26. Roper, M., Cerilo, P., Bena, J., Morrison, S., & Siegmund, L. A. (2024). Patient factors associated with treatment time for stroke before and after the onset of COVID-19. Geriatric Nursing, 56, 1-6.
27. Shah, A., & Diwan, A. (2023). Stroke thrombolysis: Beating the clock. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 27(2), 107.
28. Shinoda, J., Ichimura, S., Kanai, R., Majima, T., Azami, S., Inoue, K., & Shirai, T. (2023). Impact of JSS-PCS on the In-Hospital Workflow and Outcomes of Reperfusion Therapy for Acute Ischemic Stroke: Cases of a Metropolitan Secondary Emergency Facility. Journal of Neuroendovascular Therapy, 17(2), 37-46.
29. Souza Leite, K. F. d., Faria, M. G. B. F. d., Andrade, R. L. d. P., Sousa, K. D. L. d., Santos, S. R. d., Ferreira, K. S., . . . Monroe, A. A. (2023). Effect of implementing care protocols on acute ischemic stroke outcomes: a systematic review. Arquivos de Neuro-psiquiatria, 81, 173-185.
30. Stamm, B., Royan, R., Giurcanu, M., Messe, S. R., Jauch, E. C., & Prabhakaran, S. (2023). Door-in-door-out times for interhospital transfer of patients with stroke. JAMA, 330(7), 636-649.
31. Strilciuc, S., Ruban, A., Kalinin, M. N., Kalinin, M., & Khasanova, D. (2024). Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial.
32. Svobodová, V., Maršálková, H., Volevach, E., & Mikulík, R. (2023). Simulation-based team training improves door-to-needle time for intravenous thrombolysis. BMJ Open Quality, 12(1).
33. Thevenet, V., Lesaine, E., Domecq, S., Miganeh-Hadi, S., Maugeais, M., Rouanet, F., . . . Saillour-Glenisson, F. (2023). Alert on elongated in-hospital acute stroke management delays. An Aquitain cohort study. Revue Neurologique, 179(4), 368-372.
34. Wang, Y., Liu, G., Zhu, Y., Song, H., Ren, Y., Liu, Y., & Ma, Q. (2023). Impact of the COVID-19 pandemic on emergent stroke care in Beijing, China. Scientific Reports, 13(1), 4429.
35. Yu, L., Zhang, C., Gu, L., Chen, H., Huo, Y., Wang, S., . . . Ma, M. (2024). Hydroxysafflor Yellow A and Tenuigenin Exhibit Neuroprotection Effects Against Focal Cerebral Ischemia Via Differential Regulation of JAK2/STAT3 and SOCS3 Signaling Interaction. Molecular Neurobiology, 1-17.

Most read articles by the same author(s)

1 2 > >>